International Journal of Cancer Management

Published by: Kowsar

Prognostic Factors of Recurrence (Early and Late) and Death in Breast Cancer Patients in Iranian Women

Mohammad Esmaeil Akbari 1 , Atieh Akbari 1 , Nahid Nafissi 2 , Zeinab Shormeij 1 , Soheila Sayad 1 , Marzieh Rohani Rasaf 3 and Leyla Shojaee 1 , *
Authors Information
1 Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 Department of Surgery, Iran University of Medical Sciences, Tehran, Iran
3 School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Article information
  • Iranian Journal of Cancer Prevention: December 2016, 9 (6); e5747
  • Published Online: December 10, 2016
  • Article Type: Research Article
  • Received: February 21, 2016
  • Revised: March 2, 2016
  • Accepted: December 3, 2016
  • DOI: 10.17795/ijcp-5747

To Cite: Akbari M E, Akbari A, Nafissi N, Shormeij Z, Sayad S, et al. Prognostic Factors of Recurrence (Early and Late) and Death in Breast Cancer Patients in Iranian Women, Int J Cancer Manag. 2016 ; 9(6):e5747. doi: 10.17795/ijcp-5747.

Copyright © 2016, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136(5)-86[DOI][PubMed]
  • 2. Parkin DM, Muir CS, Whelan S, Gao YT, Ferlay J, Powell J. Cancer incidence in five continents, volume VI. 1992;
  • 3. Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol. 2003; 14 Suppl 5-49[PubMed]
  • 4. Yavari P, Hislop TG, Bajdik C, Sadjadi A, Nouraie M, Babai M, et al. Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac J Cancer Prev. 2006; 7(1): 86-90[PubMed]
  • 5. Saphner T, Tormey DC, Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol. 1996; 14(10): 2738-46[DOI][PubMed]
  • 6. Greenberg PA, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK, Buzdar AU. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol. 1996; 14(8): 2197-205[DOI][PubMed]
  • 7. Devita VT, Lawrence TS, Rosenberg SA, DePinho R, Weinberg RD. Hellman, and rosenberg's cancer: Principles and practice of oncology. 2008;
  • 8. Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E, Esmo Guidelines Working Group . Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012; 23 Suppl 7-9[DOI][PubMed]
  • 9. Rosa Mendoza ES, Moreno E, Caguioa PB. Predictors of early distant metastasis in women with breast cancer. J Cancer Res Clin Oncol. 2013; 139(4): 645-52[DOI][PubMed]
  • 10. Glück S. The importance of distant metastasis and its impact on survival rates on early-stage hormone receptor-positive breast cancer. Oncol Hematol Rev. 2007; (1): 22[DOI]
  • 11. Clark GM, Sledge GW Jr, Osborne CK, McGuire WL. Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J Clin Oncol. 1987; 5(1): 55-61[DOI][PubMed]
  • 12. Khodabakhshi Koolaee A, Falsafinejad MR, Akbari ME. The Effect of Stress Management Model in Quality of Life in Breast Cancer Women. Iran J Cancer Prev. 2015; 8(4)[DOI][PubMed]
  • 13. Largillier R, Ferrero JM, Doyen J, Barriere J, Namer M, Mari V, et al. Prognostic factors in 1,038 women with metastatic breast cancer. Ann Oncol. 2008; 19(12): 2012-9[DOI][PubMed]
  • 14. Popoola AO, Ibrahim NA, Omodele FO, Oludara MA, Adebowale SA, Igwilo AI. Pattern of spread of breast cancer among patients attending cancer unit of lagos state university teaching hospital. Asian J Med Sci. 2012; 4(3): 89-94
  • 15. Hajian Tilaki K, Auladi S. Awareness, Attitude, and Practice of Breast Cancer Screening Women, and the Associated Socio-Demographic Characteristics, in Northern Iran. Iran J Cancer Prev. 2015; 8(4)[DOI][PubMed]
  • 16. Akbari ME, Mozaffar M, Heidari A, Zirakzadeh H, Akbari A, Akbari M, et al. Recurrence and survival effect in breast conserving surgery: What are the predictive and/or prognostic factors? Iran J Cancer Prev. 2011; 4(2): 49-54
  • 17. Karimi N, Dabidi Roshan V, Fathi Bayatiyani Z. Individually and Combined Water-Based Exercise With Ginger Supplement, on Systemic Inflammation and Metabolic Syndrome Indices, Among the Obese Women With Breast Neoplasms. Iran J Cancer Prev. 2015; 8(6)[DOI][PubMed]
  • 18. Mousavi N, Mofid B, Mohebi H, Mehmannavaz M, Khousheyni S. Comparison of local recurrence, metastasis and survival rate between two surgical approaches in clinical stage I and II in breast cancer. 2009;
  • 19. Tazhibi M, Fayaz M, Mokarian F. Detection of prognostic factors in metastatic breast cancer. J Res Med Sci. 2013; 18(4): 283-90[PubMed]
  • 20. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989; 63(1): 181-7[PubMed]
  • 21. Kennecke H, McArthur H, Olivotto IA, Speers C, Bajdik C, Chia SK, et al. Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen. Cancer. 2008; 112(7): 1437-44[DOI][PubMed]
  • 22. Brewster AM, Hortobagyi GN, Broglio KR, Kau SW, Santa-Maria CA, Arun B, et al. Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst. 2008; 100(16): 1179-83[DOI][PubMed]
  • 23. Ahn SG, Lee HM, Cho SH, Bae SJ, Lee SA, Hwang SH, et al. The difference in prognostic factors between early recurrence and late recurrence in estrogen receptor-positive breast cancer: nodal stage differently impacts early and late recurrence. PLoS One. 2013; 8(5)[DOI][PubMed]
  • 24. Kennecke HF, Olivotto IA, Speers C, Norris B, Chia SK, Bryce C, et al. Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen. Ann Oncol. 2007; 18(1): 45-51[DOI][PubMed]
  • 25. Harris JR, Lippman ME, Osborne CK, Morrow M. Diseases of the breast: Lippincott williams and wilkins. 2012;
  • 26. Bosco JL, Lash TL, Prout MN, Buist DS, Geiger AM, Haque R, et al. Breast cancer recurrence in older women five to ten years after diagnosis. Cancer Epidemiol Biomarkers Prev. 2009; 18(11): 2979-83[DOI][PubMed]
  • 27. Jung SY, Rosenzweig M, Sereika SM, Linkov F, Brufsky A, Weissfeld JL. Factors associated with mortality after breast cancer metastasis. Cancer Causes Control. 2012; 23(1): 103-12[DOI][PubMed]
  • 28. Parise CA, Caggiano V. Breast cancer survival defined by the ER/PR/HER2 subtypes and a surrogate classification according to tumor grade and immunohistochemical biomarkers. J Cancer Epidemiol. 2014; 2014
  • 29. Coleman RE. Skeletal complications of malignancy. Cancer. 1997; 80(8 Suppl): 1588-94[PubMed]
  • 30. Yücel B, Bahar S, Kaçan T, Şeker MM, Celasun MG. Importance of metastasis site in survival of patients with breast cancer. Austin J Med Oncol. 2014; 1(2): 7
  • 31. Liu MT, Huang WT, Wang AY, Huang CC, Huang CY, Chang TH, et al. Prediction of outcome of patients with metastatic breast cancer: evaluation with prognostic factors and Nottingham prognostic index. Support Care Cancer. 2010; 18(12): 1553-64[DOI][PubMed]
  • 32. Beslija S, Bonneterre J, Burstein HJ, Cocquyt V, Gnant M, Heinemann V, et al. Third consensus on medical treatment of metastatic breast cancer. Ann Oncol. 2009; 20(11): 1771-85[DOI][PubMed]
  • 33. Campbell HE, Gray AM, Harris AL, Briggs AH, Taylor MA. Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK. Br J Cancer. 2010; 103(6): 776-86[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments